Clinical study to investigate the efficacy of warfarin for intractable urticaria
Not Applicable
- Conditions
- rticaria
- Registration Number
- JPRN-UMIN000010020
- Lead Sponsor
- Department of Dermatology, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
A) Patiets who take medical agents that influence on coagulation system. B) Bleeding patients. C) Patients who has the risks of bleeding. E) Patients who are recently operated or injured. F) Patients who previously had the adverse drug reaction against warfarin. And patients who can not stop taking medications which show drug interaction with warfarin. G) Patients who are pregnant or have chance of pregnancy. H) Patients who are medicated by vitamineK. I) Patiens who are pegged as unsuitable for this study by their doctor. J) Patients who has the potential of injury or contused wound by heavy exercise or work.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms and Urticarial scores before and after taking warfarin
- Secondary Outcome Measures
Name Time Method